Last reviewed · How we verify
NCT06633874: SmartSpeech
Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication
NA trial testing TD Playing the Serious Game APSOU in Developmental Language Disorders in 520 participants. Completed in 25 November 2023.
30 June 2023
Quick facts
| Lead sponsor | University of Ioannina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 520 |
| Start date | 29 March 2021 |
| Primary completion | 30 June 2023 |
| Estimated completion | 25 November 2023 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- TD Playing the Serious Game APSOU
- Non-TD Playing Serious Game
Conditions studied
- Developmental Language Disorders — all drugs for Developmental Language Disorders →
- Developmental Articulation Disorder — all drugs for Developmental Articulation Disorder →
- Speech Disorder — all drugs for Speech Disorder →
- Neurodevelopmental Disorder (Diagnosis) — all drugs for Neurodevelopmental Disorder (Diagnosis) →
Sponsor
University of Ioannina
Who can join
Adults 4 to 12, any sex, with Developmental Language Disorders or Developmental Articulation Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to justify a protocol for designing and developing an automated decision-making system to support and enhance screening and early detection procedures for developmental speech/language difficulties in child communication. The system will utilize smart computing models, sensors, and early diagnostic speech and language deficiency indicators. The study participants will be typically and non-typically (neurodevelopmentally atypical) developing children, primarily in preschool and elementary school. The key research questions the study seeks to address are: 1. Do differences exist between typically developing and neurodevelopmentally atypical children when engaging with the serious game used in the study? 2. If such differences are identified, can the collected data be utilized to train an automated decision-making system capable of accurately distinguishing between typically and neurodevelopmentally atypical children based on speech and language deficiencies? Researchers will compare typically and non-typically developed children to see if the system can incorporate multiple data points from assessment domains to create a diagnostic profile. After the parents are informed of the study and provide written consent, they enroll in the system. Participants will be asked to wear a smartwatch and play a serious game on a tablet under the supervision of a clinician. The system will collect data from the gameplay and sensors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Automated Detection of Neurodevelopmental Disorders Using Face-to-Face Mobile Technology Among Typically Developing Greek Children: Randomized Controlled Trial.
Toki EI, Zakopoulou V, Tatsis G, Pange J. · · 2024 · PMID 39393054 · DOI 10.2196/53465
Verify or expand the search:
- PubMed search for NCT06633874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Language Disorders
Currently open trials in the same condition.
- NCT06911138 — Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder · NA · recruiting
Other University of Ioannina trials
Trials by the same sponsor.
- NCT07048522 — Perioperative Intravenous Nimodipine Trial · NA · recruiting
- NCT06961825 — Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke. · NA · not yet recruiting
- NCT06758518 — Study of the Carpal Tunnel Syndrome in Relation to Stress and Depression Among Medical Students · enrolling by invitation
- NCT07164300 — Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery · NA · recruiting
- NCT07023497 — Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06633874 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Ioannina
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06633874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing